Speech-in-noise difficulties in aminoglycoside ototoxicity reflects combined afferent and efferent dysfunction
{{output}}
Objectives: Patients with Cystic fibrosis (CF) often receive aminoglycosides (AGs) to manage recurrent pulmonary infections, placing them at risk for ototoxicity. Chronic AG use can lead to complex cochlear damage affecting inner... ...
